Insufficient scRNA-seq data for expression of GDF9 at single-cell level.
Insufficient scRNA-seq data for expression of GDF9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 96.38 | 2629 / 2642 | 93% | 2.71 | 654 / 705 |
breast | 96% | 54.45 | 439 / 459 | 58% | 9.61 | 646 / 1118 |
adrenal gland | 99% | 72.19 | 256 / 258 | 52% | 0.99 | 119 / 230 |
ovary | 91% | 43.86 | 164 / 180 | 53% | 1.11 | 229 / 430 |
prostate | 99% | 71.94 | 243 / 245 | 45% | 0.82 | 226 / 502 |
thymus | 100% | 92.05 | 652 / 653 | 38% | 0.63 | 227 / 605 |
kidney | 100% | 81.82 | 89 / 89 | 34% | 0.61 | 310 / 901 |
skin | 95% | 76.99 | 1718 / 1809 | 23% | 0.40 | 107 / 472 |
uterus | 92% | 37.07 | 157 / 170 | 21% | 0.47 | 98 / 459 |
bladder | 95% | 64.19 | 20 / 21 | 15% | 0.38 | 74 / 504 |
pancreas | 99% | 66.63 | 326 / 328 | 9% | 0.24 | 16 / 178 |
esophagus | 92% | 36.56 | 1324 / 1445 | 12% | 0.21 | 22 / 183 |
liver | 91% | 35.92 | 205 / 226 | 13% | 0.18 | 51 / 406 |
stomach | 98% | 78.00 | 352 / 359 | 5% | 0.12 | 14 / 286 |
lung | 83% | 33.69 | 479 / 578 | 18% | 0.32 | 203 / 1155 |
intestine | 95% | 41.05 | 915 / 966 | 5% | 0.14 | 24 / 527 |
spleen | 99% | 51.40 | 239 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 38.50 | 1246 / 1335 | 0% | 0 | 0 / 0 |
muscle | 91% | 48.02 | 732 / 803 | 0% | 0 | 0 / 0 |
adipose | 89% | 39.05 | 1067 / 1204 | 0% | 0 | 0 / 0 |
heart | 65% | 17.96 | 556 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 33% | 17.28 | 308 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.20 | 4 / 29 |
eye | 0% | 0 | 0 / 0 | 13% | 0.17 | 10 / 80 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.09 | 3 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001555 | Biological process | oocyte growth |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0007292 | Biological process | female gamete generation |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_2000870 | Biological process | regulation of progesterone secretion |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005615 | Cellular component | extracellular space |
GO_0005737 | Cellular component | cytoplasm |
GO_0005125 | Molecular function | cytokine activity |
GO_0008083 | Molecular function | growth factor activity |
Gene name | GDF9 |
Protein name | Growth/differentiation factor 9 (GDF-9) Growth/differentiation factor 9 |
Synonyms | |
Description | FUNCTION: Required for ovarian folliculogenesis. Promotes primordial follicle development. Stimulates granulosa cell proliferation. Promotes cell transition from G0/G1 to S and G2/M phases, through an increase of CCND1 and CCNE1 expression, and RB1 phosphorylation. It regulates STAR expression and cAMP-dependent progesterone release in granulosa and thecal cells. Attenuates the suppressive effects of activin A on STAR expression and progesterone production by increasing the expression of inhibin B. It suppresses FST and FSTL3 production in granulosa-lutein cells. . |
Accessions | ENST00000687214.1 ENST00000378673.2 O60383 A0A8I5KUL2 ENST00000624495.4 B4DXG3 ENST00000296875.4 ENST00000464378.2 ENST00000621295.5 ENST00000624492.4 ENST00000687138.1 |